FBT

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund seeks investment results that correspond to the price and yield of an equity index called the Amex Biotechnology Index.


US

EQUITY

Rules-Based

MANAGEMENT STYLE

56 bp

EXPENSES

$6.9 B

ASSETS UNDER MGMT

FACTOR SCORECARD

SIZE
VALUE
YIELD
MOMENTUM
VOLATILITY
QUALITY
Fund Basics
Fund sponsorFirst Trust Advisors LP
CategoryUS
Asset classEquity
Websitelink...
Inception dateJun 19, 2006
Assets (mns)$6,948
Expense ratio56 bp
CurrencyUSD
Sector Breakdown
Fund Structure
RegulationOpen-Ended Fund
DistributionsQuarterly
Taxation1099
Stock selectionMarket Cap
WeightingEqual
Holdings TransparencyFull
Derivatives-basedNo
Options availableYes
Currency hedgedNo
Fund of fundsNo
Top 10 Holdings Complete list  + 
ALNYLAM PHARMACEUTICALS INC 4.6 %
CORCEPT THERAPEUTICS INC 4.3 %
UNITED THERAPEUTICS CORP 4.2 %
HALOZYME THERAPEUTICS INC 4.1 %
ARGENX SE ADR 3.7 %
VERTEX PHARMACEUTICALS INC 3.7 %
AMGEN INC 3.7 %
INCYTE CORP 3.7 %
REGENERON PHARMACEUTICALS 3.5 %
MODERNA, INC. 3.5 %
Constituent Breakdown
Number of holdings186
Herfindahl-Hirschman Index 347
Wgt avg mkt cap (mns)$31,525
Large cap (>$10bn)62.4%
Mid cap ($2-10bn)31.5%
Small cap (<$2bn)6.1%
Developed mkts.100.0%
Emerging mkts.0.0%
Country Exposure
UNITED STATES 83.6 %
NETHERLANDS 3.7 %
CHINA 3.4 %
IRELAND 3.2 %
GERMANY 3.1 %
DENMARK 3.0 %
Historical Performance


Standardized Performance (as of 06/30/2024)
 YTD1 YR2 YR3 YR5 YR10 YRIncep.
Total Returns -4.5% -1.4% 5.5% -4.4% 1.4% 6.1% 11.9%
Volatility 16.1% 17.1% 20.5% 21.8% 23.9% 25.2% --
Market Correlations
versus...BetaR-squared
S&P 5000.7051%
MSCI EAFE0.7555%
MSCI Emg Mkts0.6441%
Liquidity Measures
Avg. volume (000)18
Turnover0.0%
Avg. Bid/Ask (% of price)0.20%
ADV of underlying (mns)$10,457
Technical Indicators
Recent close$160.20
30d moving avg.$151.00
Annualized volatility17.6%
Relative strength (RSI)55
Short interest (ETF)0.0%
Short interest (underlying)5.3%
Distributions
Assets Under Management (mns)

Money Flows (mns)

Short Interest (as % of shares outstanding)

Long Money Flows (mns)

Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial

Risk and Returns: FBT vs. Comps (1 YR)

Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Results & Estimates
  2019 2020 2021 2022 2023 2024E 2025E  
Sales per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Earnings per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Dividends per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Book value per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Valuation Metrics
  2023 2024E Fwd Est 2025E
Price-to-sales --x --x --x --x
Price-to-earnings --x --x --x --x
Price-to-cash flow --x --x --x --x
Price-to-growth --x --x --x --x
Price-to-book value --x --x --x --x
Yield --% --% --x --%
5.2 34.3 3.8 0.3% --
Based on closing prices from 7/19/2024
Historical Valuation Trends Sample data. Subscribe for access.

SHOWING:
Price-to-Earnings
FBT



Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.

Some content on this tab for Individual & Professional subscribers only. Start your FREE trial

ETF Research Center Fund Rating

Our measure of an ETF's overall investment merit

ALTAR Score™

FBT

2.1%

Cat. Avg

5.7%

Fund Category: US

Avg. Return on Equity--%
Divided by: Fwd. P/BV--x
Less: Expenses-- bp
Equals: ALTAR Score™2.1%
Recommendation

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may be less relevant.

Category Overview
There are 899 funds in the US category, with an average ALTAR Score™ of 5.7% and a standard deviation of 2.5%. FBT's ALTAR Score™ is approximately 1.5 standard deviations below the category average. This places FBT in the 7th percentile among funds in the category.
Consensus Recommendation

Sell-side recommendations on the ETF's individual constituents

Composite
FBT
Peer Average
SELL
U/W
HOLD
O/W
BUY



Recent Trends


Breakdown
Expense Analysis

Peer Group Rules-Based
US Equity ETFs
# of ETFs 609
Avg. Expense Ratio 46.6 bp
Std. Deviation 32.9 bp
FBT (56 bp) Percentile rank 61
Peer Group Expense Ratio Distribution


Total Cost of Ownership (TCO) Comparison
Expense (bp)
(A)
Avg. Bid/Ask (bp)
(B)
TCO (bp)
(A)+(B)
FBT 56.0 20.2 76.2
Peer Avg. 44.3 17.3 61.6
  For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .